1192-80-9 Usage
General Description
3-(Chloromethyl)-5-methyl-1,2,4-oxadiazole is a chemical compound with the molecular formula C4H6ClN3O. It is a heterocyclic organic compound that contains both nitrogen and oxygen atoms in its five-membered ring structure. 3-(CHLOROMETHYL)-5-METHYL-1,2,4-OXADIAZOLE is commonly used in the synthesis of various pharmaceuticals, agrochemicals, and other organic compounds due to its versatility and reactivity. It can also be used as a building block in the preparation of new materials and has applications in the field of medicinal chemistry and drug development. However, it is important to handle this chemical with proper care and precautions, as it is considered to be hazardous and may have harmful effects if not used properly.
Check Digit Verification of cas no
The CAS Registry Mumber 1192-80-9 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,1,9 and 2 respectively; the second part has 2 digits, 8 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 1192-80:
(6*1)+(5*1)+(4*9)+(3*2)+(2*8)+(1*0)=69
69 % 10 = 9
So 1192-80-9 is a valid CAS Registry Number.
InChI:InChI=1/C4H5ClN2O/c1-3-6-4(2-5)7-8-3/h2H2,1H3
1192-80-9Relevant articles and documents
-
Borthwick,A.D. et al.
, p. 2769 - 2772 (1973)
-
SUBSTITUTED OXOPYRIDINE DERIVATIVES
-
Paragraph 0842; 0843; 0844; 0845, (2017/10/27)
The invention relates to substituted oxopyridine derivatives and to processes for preparation thereof, and also to the use thereof for production of medicaments for treatment and/or prophylaxis of diseases, especially of cardiovascular disorders, preferably thrombotic or thromboembolic disorders, and oedemas, and also ophthalmic disorders.
NEW COMPOUNDS
-
Page 43, (2010/02/06)
The present invention relates to new compounds of formula I, wherein P Q X1 X2 X3 X4 X5 R R1 R2 R3 R4R5 G M1 M2 M3 m and n are defined as in formula I, a process for their preparation and new intermediates prepared therein, pharmaceutical formulations containing said compounds and to the use of said compounds in therapy.